Epigral Limited (NSE:EPIGRAL)
India · Delayed Price · Currency is INR 1,246.80
-53.70 (-4.13%)
May 12, 2026, 3:30 PM IST
Epigral Revenue
In the fiscal year ending March 31, 2026, Epigral had annual revenue of 25.42B INR, down -0.31%. Epigral had revenue of 7.36B in the quarter ending March 31, 2026, with 17.20% growth.
Revenue
25.42B
Revenue Growth
-0.31%
P/S Ratio
2.12
Revenue / Employee
23.71M
Employees
1,072
Market Cap
53.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 25.42B | -79.70M | -0.31% |
| Mar 31, 2025 | 25.50B | 6.21B | 32.19% |
| Mar 31, 2024 | 19.29B | -2.59B | -11.84% |
| Mar 31, 2023 | 21.88B | 6.37B | 41.10% |
| Mar 31, 2022 | 15.51B | 7.22B | 87.18% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gujarat Narmada Valley Fertilizers & Chemicals | 76.20B |
| Gujarat Alkalies and Chemicals | 43.08B |
| Chemplast Sanmar | 41.19B |
| GHCL Limited | 31.38B |
| The Andhra Sugars | 23.29B |
| DCW Limited | 21.63B |
| Godavari Biorefineries | 20.07B |
| Archean Chemical Industries | 11.26B |